Picture of H&R GmbH & Co KgaA logo

2HRA H&R GmbH & Co KgaA Share Price

0.000.00%
de flag iconLast trade - 00:00
Basic MaterialsBalancedSmall CapContrarian

Momentum

Relative Strength (%)
1m+1.98%
3m+12.32%
6m+11.71%
1yr-14.46%
Volume Change (%)
10d/3m-25.9%
Price vs... (%)
52w High-18.95%
50d MA+6.65%
200d MA+9.83%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.42
PEG Ratio (f)1.26
EPS Growth (f)9.96%
Dividend Yield (f)2.49%
Valuation (ttm)IndustryMarket
Price to Book Value0.36
Price to Tang. Book0.39
Price to Free Cashflow10.14
Price to Sales0.12
EV to EBITDA3.37

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.47%
Return on Equity2.53%
Operating Margin2.41%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue€m873.031,188.431,576.041,352.261,338.241,355.031,390.334.47%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a-12.7-71-0.74-5.86+46.06n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of H&R GmbH & Co KgaA EPS forecast chart

Profile Summary

H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
August 1st, 2016
Public Since
December 21st, 1953
No. of Employees
1,705
Sector
Chemicals
Industry
Basic Materials
Exchange
de flag iconXETRA
Shares in Issue
37,221,746
Blurred out image of a map
Address
Neuenkirchener Str. 8, SALZBERGEN, 48499
Web
https://www.hur.com/
Phone
+49 59769450
Contact
Ties Kaiser
Auditors
Grant Thornton AG Wirtschaftsprüfungsgesellschaft

2HRA Share Price Performance

Upcoming Events for 2HRA

Q1 2025 H&R GmbH & Co KgaA Earnings Release

H&R GmbH & Co KgaA Annual Shareholders Meeting

Dividend For 2HR.DE - 0.1000 EUR

H&R GmbH & Co KgaA Annual Shareholders Meeting

Q2 2025 H&R GmbH & Co KgaA Earnings Release

Similar to 2HRA

FAQ